Prevention of non-communicable diseases in citizens with low income, migrants and ethnic minorities Other
Conditions
Interventions
In Spain, participants will be randomly assigned in a 1:1 ratio to either the intervention group or the control group. Randomization will be performed using computer-generated random numbers to ensure
Sponsors
Universitat de València
Erasmus MC
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Adults 18 years and older 2. Inhabitants of selected neighbourhoods within one of the pilot sites (Rijeka, Rotterdam and Valencia) 3. Able to give informed consent 4. Comprehension of the local language 5. Belong to one (or more) of the following groups: 5.1. General population from the selected vulnerable neighbourhood 5.2. Socially disadvantaged populations including low-income populations, migrants and ethnic minorities 5.3. Individuals who are at risk for NCDs or already have type 2 diabetes and/or CVD
Exclusion criteria
Exclusion criteria: 1. Individuals under the age of 18 years 2. Individuals living outside selected neighbourhoods 3. Individuals with severe or terminal illnesses unrelated to NCDs that could affect their ability to participate in the study 4. Participants with conditions requiring intensive medical care or beyond the intervention capabilities of the project 5. Individuals who do not fulfil the socioeconomic or ethnic criteria specified in the inclusion criteria 6. Individuals who do not consent or who are unwilling to participate in the data collection and study activities
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| 1. Self-efficacy is measured using the Nutrition Self-Efficacy Scale, Physical Exercise Self Efficacy Scale, and Alcohol Resistance Self Efficacy Scale at baseline and after 9 months. 2. Body Mass Index (BMI) is measured by asking length and weight of the participant at baseline and after 9 months 3. Chronic conditions are measured using the Cumulative Illness Rating Scale (CIRS) at baseline and after 9 months 4. Lifestyle advice is measured by core items of the WHO STEPwise approach to noncommunicable disease risk factor surveillance (WHO STEPS) at baseline and after 9 months 5. Health-Related Quality of Life is measured by the Patient Reported Outcomes Measurement Information System 10-Question Short Form (PROMIS-10) at baseline and after 9 months 6. Neighbourhood belonging is measured by 15 items in the Neighbourhood Cohesion Scale at baseline and after 9 months Implementation outcomes will be continuously measured with administrative data, questionnaire data and qualitative data in terms of acceptability, appropriateness, feasibility, adoption, penetration, implementation costs, and sustainability following the taxonomy of Proctor et al. (2011). | — |
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measure of lifestyle is measured using the following variables of diet, physical activity, alcohol consumption and smoking: 1. Diet is measured using the Rapid Prime Diet Score Screener (rPDQS) at baseline and after 9 months 2. Physical activity is measured using the International Physical Activity Questionnaire (IPAQ-SF) at baseline and after 9 months 3. Alcohol consumption is measured using the Alcohol Use Disorders Identification Test (AUDIT-C) at baseline and after 9 months 4. Smoking status is measured with 4 items, including the use of vapes at baseline and after 9 months. | — |
Countries
Croatia, Netherlands, Spain
Contacts
Public ContactTamara Alhambra Borrás
Outcome results
None listed